Roivant Sciences (ROIV) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free ROIV Stock Alerts $10.86 -0.04 (-0.37%) (As of 03:21 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRoivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosisbusinesswire.com - April 25 at 8:00 AMRoivant Sciences: Cashing In On Vants And Venturesseekingalpha.com - April 24 at 3:15 PMRoivant Sciences (NASDAQ:ROIV) Given "Buy" Rating at HC Wainwrightamericanbankingnews.com - April 23 at 3:26 AMRoivant Sciences (NASDAQ:ROIV) Rating Reiterated by HC Wainwrightmarketbeat.com - April 22 at 8:29 AMSunrun (RUN) Gets a Buy from RBC Capitalmarkets.businessinsider.com - April 14 at 7:09 AMVanguard Group Inc. Has $65.44 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - April 8 at 4:08 AMResearch Analysts Issue Forecasts for Roivant Sciences Ltd.'s Q1 2025 Earnings (NASDAQ:ROIV)marketbeat.com - April 5 at 8:51 AMRoivant's anti-inflammatory drug shows promise in mid-stage studymsn.com - April 4 at 8:54 AMRoivant Sciences (NASDAQ:ROIV) Sees Large Volume Increase Following Analyst Upgrademarketbeat.com - April 3 at 2:33 PMRoivant Sciences (NASDAQ:ROIV) Given New $18.00 Price Target at The Goldman Sachs Groupmarketbeat.com - April 3 at 12:14 PMRoivant Sciences Ltd. (NASDAQ:ROIV) Given Average Recommendation of "Moderate Buy" by Analystsmarketbeat.com - April 3 at 2:21 AMRoivant Sciences Sees Unusually High Options Volume (NASDAQ:ROIV)marketbeat.com - April 2 at 12:28 PMRoivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.43marketbeat.com - April 2 at 10:48 AMRoivant Sciences Stock Flirts With Breakout On 'Extremely Positive' Eye-Disease Studymsn.com - April 2 at 9:56 AMRoivant's anti-inflammatory drug succeeds in mid-stage studyreuters.com - April 2 at 7:28 AMRoivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Millionglobenewswire.com - April 2 at 7:00 AMCompare with CoinDesk Market Index (CDICMI)msn.com - April 1 at 1:50 PMAssenagon Asset Management S.A. Has $11.94 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 29 at 5:16 AMRoivant Sciences (NASDAQ:ROIV) Shares Down 4% marketbeat.com - March 28 at 5:39 PMRoivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.08marketbeat.com - March 27 at 11:47 AMViking Therapeutics gains on early data for oral weight loss therapymsn.com - March 26 at 8:38 AM'Some people have principles': Internet divided as Vivek Ramaswamy predicts NY ruling against Trump could energize key voter groupmsn.com - March 26 at 8:38 AMTruist Financial Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)marketbeat.com - March 25 at 1:10 PMRoivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.01marketbeat.com - March 21 at 3:14 PMRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by Citigroup Inc.marketbeat.com - March 17 at 5:10 AMRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by Wellington Management Group LLPmarketbeat.com - March 16 at 5:34 AMInvestors Purchase Large Volume of Roivant Sciences Put Options (NASDAQ:ROIV)marketbeat.com - March 15 at 8:18 PML'objectif de cours de Roivant Sciences relevé à 16$ par Goldman Sachsfr.investing.com - March 14 at 8:20 AMMorgan Stanley Buys 6,324,915 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 14 at 4:40 AMTravere Therapeutics, Inc.edition.cnn.com - March 13 at 5:05 PMTD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)markets.businessinsider.com - March 13 at 12:04 PMCalifornia State Teachers Retirement System Sells 101,449 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 12 at 4:47 AMTejara Capital Ltd Has $4.19 Million Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 6 at 5:40 PMRegal Partners Ltd Acquires Shares of 100,000 Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 5 at 8:14 PMLaurion Capital Management LP Trims Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 4 at 1:35 PMArdsley Advisory Partners LP Has $5.26 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 3 at 10:59 AMBank of Nova Scotia Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - March 1 at 7:31 AMRoivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lifted by Deerfield Management Company L.P. Series Cmarketbeat.com - February 28 at 2:12 PMAvidity Partners Management LP Decreases Position in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - February 27 at 4:25 PMRoivant Sciences Ltd. (NASDAQ:ROIV) Position Boosted by Monashee Investment Management LLCmarketbeat.com - February 25 at 10:47 AMCharles Schwab Investment Management Inc. Has $22.47 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - February 23 at 4:34 AMRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Citigroup Inc.marketbeat.com - February 21 at 5:44 AMFmr LLC Purchases 2,913,491 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - February 20 at 7:31 AMSilverarc Capital Management LLC Invests $1.17 Million in Roivant Sciences Ltd. (NASDAQ:ROIV)marketbeat.com - February 18 at 12:54 PMRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by State of New Jersey Common Pension Fund Dmarketbeat.com - February 17 at 6:39 AMBuy Rating Affirmed for Roivant Sciences: Undervaluation and Promising Pipeline Drive Positive Outlookmarkets.businessinsider.com - February 15 at 9:16 AMDo You Think the Management of Roivant Sciences (ROIV) Can Create Value?finance.yahoo.com - February 15 at 4:15 AMRoivant Sciences (NASDAQ:ROIV) Price Target Cut to $17.00 by Analysts at HC Wainwrightmarketbeat.com - February 14 at 12:26 PMRoivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcriptmsn.com - February 14 at 12:19 PMHold Rating on Roivant Sciences Amidst Mixed Performance and Strategic Focusmarkets.businessinsider.com - February 14 at 12:19 PM Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry ROIV Media Mentions By Week ROIV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼0.440.42▲Average Medical News Sentiment ROIV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼66▲ROIV Articles Average Week Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMGN News Today RYZB News Today CRNX News Today BIO News Today QGEN News Today ASND News Today LEGN News Today PEN News Today HSIC News Today RGEN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
